Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet Luciano Artur Lopes Pereira; Catarina Meng; Manuel Augusto Gonçalves Amoedo; Maria Teresa de Sousa Costa Pinto Ferreira Mendes; Marco Alexandre Mateus Prazeres Marques; João Miguel Machado Dória Frazão; André Luiz Loureiro Weigert;

Hyporesponsiveness or resistance to the action of parathyroid hormone in chronic kidney disease Jordi Bover; Carolt Arana; Pablo Ureña; Armando Torres; Alejandro Martín-Malo; Leonor Fayos; Verónica Coll; María Jesús Lloret; Jackson Ochoa; Yolanda Almadén; Lluis Guirado; Mariano Rodríguez;

Efficacy and safety of sucroferric oxyhydroxide in the treatment of hyperphosphataemia in chronic kidney disease in Asturias. FOSFASTUR study J. Emilio Sanchez-Alvarez; Elena Astudillo Cortés; Miguel Seras Mozas; Raúl García Castro; Carlos Miguel Hidalgo Ordoñez; Ana Cristina Andrade López; Catalina Ulloa Clavijo; Anna Gallardo Pérez; Carmen Rodríguez Suarez;